TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Philip Morris International: Why 2026 Could Be the Tipping Point for Its Smoke-Free Dominance

The Motley Fool Logo The Motley Fool By Justin Pope
Philip Morris International: Why 2026 Could Be the Tipping Point for Its Smoke-Free Dominance

Philip Morris International is positioning itself for significant growth in the smoke-free nicotine market, with potential FDA approval for Iqos Iluma in the US and strong performance in alternative nicotine products like Zyn.

Insights
PM   positive

Strong market position in smoke-free products, 41% revenue from alternative nicotine products, potential US market expansion, 72% success rate in converting smokers, projected 11% earnings growth